Spotlight on Science Meetings, Conferences and Events brings you information on the following event: Tumor Models Boston 2017
The 5th Annual Tumor Models Boston Summit continues to showcase the latest advancements in the application of preclinical models to enhance the translation of cancer therapies from animal to patient. It will address the preclinical & clinical developments of the most promising therapies including targeted therapies, check-point inhibitors & CAR-T therapies and how these findings can be utilized to bridge the gap between preclinical and clinical studies.
Attendees will learn how the industry have been selecting & characterizing in vitro models, ex vivo assays, syngeneic models, PDX, humanized mice models to optimize their application in preclinical and translational studies for targeted therapies, cancer immunotherapies and combination therapies.
Join to uncover the valuable clinical lessons that are helping to transform preclinical research through reverse translation and to extract more value from preclinical models to enhance preclinical and translational decision making into the clinic.
Top benefits of attending include:
1. Optimize your pre-clinical studies
2. Advance model selection and characterization
3. Discover translational insights from the clinic
View the Full Event Guide for exclusive updates on our agenda, speakers, workshops, discounts and more: http://tumor-models.com/about/brochure/
The Colonnade Hotel
Boston, MA
Tuesday, July 18, 2017 to Thursday, July 20, 2017
